The Brazillian city of Niteroi in Rio-de Janeiro has begun trial of Chinese pharmaceutical company Sinovac made Coronavirus vaccine,
800 of the city's healthcare workers have already applied to participate in the research as volunteers to receive the Coronavirus vaccine.
It's expected 9,000 volunteers in total from five other Brazillian states will be participating.
Rafael Bastos, an anesthesiologist who volunteered to receive the COVID-19 vaccine, is confident enough that the trial will be a success.
"Three tests for COVID-19 were previously done. Actually, I did 12 tests for COVID-19. I haven't had contact with the Coronavirus yet, beside being on the front line. So I was eligible to take the vaccine (for the trial). We participated and we are confident with the result. So it can solve our public health problem not only in Brazil but also in the World," Bastos said Tuesday.
Sinovac, the Chinese Pharmeceutical Company producing the vaccine, began research on the drug in January 2020. No severe adverse effects were reported in phase1 and 2 of trials. The vaccine reportedly triggers antibodies 14days following the injection. Researchers can get results faster by testing vaccines where active virus spread is rampant.
According to the Johns Hopkins University data, Brazil has reported more than 3.9 million infected cases and 121,382 deaths, making it the second worst-hit country in the world after the United States of America.